336 related articles for article (PubMed ID: 9456293)
1. Phase II-selective induction of hepatic drug-metabolizing enzymes by oltipraz -5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione-, 1,7-phenanthroline, and 2,2'-dipyridyl in rats is not accompanied by induction of intestinal enzymes.
Vargas M; Lamb JG; Franklin MR
Drug Metab Dispos; 1998 Feb; 26(2):91-7. PubMed ID: 9456293
[TBL] [Abstract][Full Text] [Related]
2. Early events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: comparison with oltipraz, tert-butyl-4-hydroxyanisole, and tert-butylhydroquinone.
Lamb JG; Franklin MR
Drug Metab Dispos; 2000 Sep; 28(9):1018-23. PubMed ID: 10950843
[TBL] [Abstract][Full Text] [Related]
3. Drug-metabolizing enzyme induction by 2,2'-dipyridyl, 1,7-phenanthroline, 7,8-benzoquinoline and oltipraz in mouse.
Carr BA; Franklin MR
Xenobiotica; 1998 Oct; 28(10):949-56. PubMed ID: 9849642
[TBL] [Abstract][Full Text] [Related]
4. Induction of drug metabolizing enzymes by 1,7-phenanthroline and oltipraz in mice is unrelated to Ah-responsiveness.
Carr BA; Franklin MR
J Biochem Mol Toxicol; 1999; 13(2):77-82. PubMed ID: 9890192
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
Davidson NE; Egner PA; Kensler TW
Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812
[TBL] [Abstract][Full Text] [Related]
6. Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley rats.
Begleiter A; Sivananthan K; Curphey TJ; Bird RP
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):566-72. PubMed ID: 12815004
[TBL] [Abstract][Full Text] [Related]
7. Developmental aspects of glucocorticoid regulation of polycyclic aromatic hydrocarbon-inducible enzymes in rat liver.
Linder MW; Prough RA
Arch Biochem Biophys; 1993 Apr; 302(1):92-102. PubMed ID: 8470911
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
[TBL] [Abstract][Full Text] [Related]
9. Drug metabolizing enzyme induction by benzoquinolines, acridine, and quinacrine; tricyclic aromatic molecules containing a single heterocyclic nitrogen.
Le HT; Lamb JG; Franklin MR
J Biochem Toxicol; 1996; 11(6):297-303. PubMed ID: 9176741
[TBL] [Abstract][Full Text] [Related]
10. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
[TBL] [Abstract][Full Text] [Related]
11. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
[TBL] [Abstract][Full Text] [Related]
12. Effect of selective phase II enzyme inducers on glucuronidation of benoxaprofen in rats.
Dong JQ; Etheridge AS; Smith PC
Drug Metab Dispos; 1999 Dec; 27(12):1423-8. PubMed ID: 10570023
[TBL] [Abstract][Full Text] [Related]
13. Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol.
Horn TL; Long L; Cwik MJ; Morrissey RL; Kapetanovic IM; McCormick DL
Chem Biol Interact; 2005 Apr; 152(2-3):79-99. PubMed ID: 15840382
[TBL] [Abstract][Full Text] [Related]
14. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
McMahon M; Itoh K; Yamamoto M; Chanas SA; Henderson CJ; McLellan LI; Wolf CR; Cavin C; Hayes JD
Cancer Res; 2001 Apr; 61(8):3299-307. PubMed ID: 11309284
[TBL] [Abstract][Full Text] [Related]
15. Induction of hepatic glutathione S-transferase and UDP-glucuronosyltransferase activities by ketamine in rats.
Chan WH; Su HC; Hung MH; Sun WZ; Fan SZ; Hsiao PN; Ueng TH
Acta Anaesthesiol Taiwan; 2008 Mar; 46(1):2-7. PubMed ID: 18390394
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of glutathione transferase, glutathione transferase messenger RNA, and reduced nicotinamide adenine dinucleotide (phosphate):quinone reductase induction by 2(3)-tert-butyl-4-hydroxyanisole in mice.
Benson AM; Hunkeler MJ; Morrow JF
Cancer Res; 1984 Nov; 44(11):5256-61. PubMed ID: 6435866
[TBL] [Abstract][Full Text] [Related]
17. Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice.
El-Sayed WM; Aboul-Fadl T; Lamb JG; Roberts JC; Franklin MR
Toxicology; 2006 Mar; 220(2-3):179-88. PubMed ID: 16451816
[TBL] [Abstract][Full Text] [Related]
18. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.
Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL
Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer.
Srinivasan P; Suchalatha S; Babu PV; Devi RS; Narayan S; Sabitha KE; Shyamala Devi CS
Chem Biol Interact; 2008 Apr; 172(3):224-34. PubMed ID: 18336807
[TBL] [Abstract][Full Text] [Related]
20. Hepatic chemoprotective enzyme responses to 2-substituted selenazolidine-4(R)-carboxylic acids.
El-Sayed WM; Franklin MR
J Biochem Mol Toxicol; 2006; 20(6):292-301. PubMed ID: 17163488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
